Evy Lundgren-Åkerlund-arkiv - BioStock

ADC deals

Targinta’s CEO: “Strong interest in ADCs in 2023”

22 January, 2024

Xintela

Xintela highlights the unique properties of XSTEM

30 May, 2023

Targinta

Targinta positions itself in the ADC field

22 March, 2023

Xintela

Xintela’s strategy for 2023

17 February, 2023

Xintela

Xintela presents the plans for 2022 in its Q4 report

4 March, 2022

Xintela

Xintela advances to clinical phase in OA and difficult-to-heal wounds in...

19 January, 2022

Xintela

Xintela approaches the market with EQSTEM

3 November, 2021

Xintela signs agreement with CRO for phase I/II study

12 August, 2021

Xintela’s CEO on recent successes

30 March, 2021